➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
McKinsey
Baxter
Medtronic
Merck

Last Updated: April 10, 2021

DrugPatentWatch Database Preview

Litigation Details for Route1 Inc. v. AirWatch LLC (D. Del. 2017)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Route1 Inc. v. AirWatch LLC (D. Del. 2017)

Docket   Start Trial Date Filed 2017-03-27
Court District Court, D. Delaware Date Terminated 2019-10-07
Cause 28:1338 Patent Infringement Assigned To Kent A. Jordan
Jury Demand Plaintiff Referred To
Parties AIRWATCH LLC; ROUTE1 INC.; VMWARE, INC.
Patents 6,695,722; 7,981,905; 8,562,979; 8,562,981; 8,642,858; 8,858,987; 8,905,979; 8,987,554; 9,572,814; 9,814,722; 9,987,285
Attorneys Aaron M. Williams; Anne Shea Gaza; Bita Rahebi; Christine E. Duh; Christopher J. Wiener; Cynthia D. Vreeland; Dana O. Burwell; Dominick T. Gattuso; Elena C. Norman; Elizabeth Ann Patterson; Marcel C. Duhamel; Michael H. Smith; Michael J. Garvin; Peter M. Dichiara; Rex W. Miller; Richard S.J. Hung; Samantha G. Wilson; William F. Lee; William H. Oldach
Firms Heyman Enerio Gattuso & Hirzel LLP; Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Route1 Inc. v. AirWatch LLC
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Route1 Inc. v. AirWatch LLC

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Route1 Inc. v. AirWatch LLC (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
2020-04-23 334 Opinion - Memorandum Opinion a flat hourly rate for all attorneys of $695 in 2018 and $722 in 2019. That is a reasonable rate for … asserted infringement of U.S. Patent No. 7,814,216 (the “’216 patent”). After I construed disputed …infringement claim, “the technology described in the ’216 patent is directed to a means for remote computing access…communication network. (’216 Pat. 1:7-10.) The ’216 patent claims a method by which users of ‘remote devices…the “instruction limitation,” of claim 1 of the patent. That limitation states that the controller sends External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
AstraZeneca
Express Scripts
Merck
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.